Dr. Ralph Hauke, MD
Claim this profileNebraska Cancer Specialists
About Ralph Hauke, MD
Education:
- Obtained MD (Doctor of Medicine) from the University of Nebraska Medical Center in 1986.
- Completed Residency in Internal Medicine at the University of Nebraska Medical Center in 1989.
- Finished Fellowship in Hematology/Oncology at the University of Nebraska Medical Center in 1991.
Experience:
- Currently practices as an oncologist and hematologist at Nebraska Cancer Specialists.
- Extensive training and medical education at the University of Nebraska Medical Center.
Area of expertise
Prostate Cancer
Ralph Hauke, MD has run 12 trials for Prostate Cancer. Some of their research focus areas include:
Lung Cancer
Ralph Hauke, MD has run 9 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Nebraska Cancer Specialists
Nebraska Methodist Hospital
Clinical Trials Ralph Hauke, MD is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
Long-Term Safety of AAA617
for Prostate Cancer
The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \[177Lu\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as possible) any other AAA617 causally related serious adverse event(s) in the long-term in adults with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials.
Recruiting
3 awards
Phase 4
More about Ralph Hauke, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 36 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Ralph Hauke, MD has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Docetaxel
- Cisplatin
- Prednisone
Breakdown of trials Ralph Hauke, MD has run
Prostate Cancer
Lung Cancer
Melanoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ralph Hauke, MD specialize in?
Ralph Hauke, MD focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Ralph Hauke, MD currently recruiting for clinical trials?
Yes, Ralph Hauke, MD is currently recruiting for 6 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Ralph Hauke, MD has studied deeply?
Yes, Ralph Hauke, MD has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Ralph Hauke, MD?
Apply for one of the trials that Ralph Hauke, MD is conducting.
What is the office address of Ralph Hauke, MD?
The office of Ralph Hauke, MD is located at: Nebraska Cancer Specialists, Omaha, Nebraska 68114 United States. This is the address for their practice at the Nebraska Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.